Company Profile
Clearside Biomedical Stock Price, News & Analysis
Company overview
Business overview
Clearside Biomedical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Clearside Biomedical is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Clearside Biomedical makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Clearside Biomedical trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Why the stock is moving
CLSD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant. The market will care about whether the delivery method still differentiates the story.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Source: Clearside Biomedical
- 02
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
Source: Clearside Biomedical
- 03
- 04
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
Source: Clearside Biomedical
- 05
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
Source: Clearside Biomedical
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.